/ /

  • linkedin
  • Increase Font
  • Sharebar

    New wavefront indication enhances treatment for mixed astigmatism

    Patient segment can be challenging to treat with LASIK

    Patients with mixed astigmatism can be challenging to treat with LASIK. The recent FDA approval of a new indication for wavefront-guided technology (iDesign Advanced WaveScan Studio System, Abbott) could make treatment for this patient segment a little easier. 

    Related: Pulse technology boosts all-laser PRK for one-step, no-touch ablation

    Used in tandem with an excimer laser system (Star S4 IR, Abbott), the wavefront technology provides surgeons with detailed information for precise and individualized treatment. Previously approved for hyperopia, myopia, and astigmatism, the approval with mixed astigmatism helps reach another potential group of patients, said Robert K. Maloney, MD, Los Angeles. He was involved with FDA trials for the system and has used it for about 4 years.

    About 5% of his patients have mixed astigmatism. Though this may seem a small percentage, it is a large enough chunk that surgeons would not want to turn them away, he noted.

    More: Clinicians coming to terms with dysfunctional lens syndrome

    “It’s not terribly common, but if you want to be a comprehensive refractive surgeon, you have to be able to handle those patients,” he said.

    Rising to the challenge

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results